186 related articles for article (PubMed ID: 36314067)
41. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
[TBL] [Abstract][Full Text] [Related]
42. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
43. The role of transketolase in human cancer progression and therapy.
Hao S; Meng Q; Sun H; Li Y; Li Y; Gu L; Liu B; Zhang Y; Zhou H; Xu Z; Wang Y
Biomed Pharmacother; 2022 Oct; 154():113607. PubMed ID: 36030587
[TBL] [Abstract][Full Text] [Related]
44. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
Xu X; Zur Hausen A; Coy JF; Löchelt M
Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
[TBL] [Abstract][Full Text] [Related]
45. Regulating TKT activity inhibits proliferation of human acute lymphoblastic leukemia cells.
Huang FL; Chang YM; Lin CY; Yu SJ; Fu JT; Chou TY; Yeh SW; Liao EC; Li CL
Am J Cancer Res; 2024; 14(2):679-695. PubMed ID: 38455402
[TBL] [Abstract][Full Text] [Related]
46. S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma.
Zeng X; Guo H; Liu Z; Qin Z; Cong Y; Ren N; Zhang Y; Zhang N
Cell Death Dis; 2022 Jun; 13(6):568. PubMed ID: 35752610
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
Zhou X; Zhu A; Gu X; Xie G
Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
[TBL] [Abstract][Full Text] [Related]
48. Transketolase regulates sensitivity to APR-246 in p53-null cells independently of oxidative stress modulation.
Milne JV; Zhang BZ; Fujihara KM; Dawar S; Phillips WA; Clemons NJ
Sci Rep; 2021 Feb; 11(1):4480. PubMed ID: 33627789
[TBL] [Abstract][Full Text] [Related]
49. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression.
Baptista I; Karakitsou E; Cazier JB; Günther UL; Marin S; Cascante M
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408935
[TBL] [Abstract][Full Text] [Related]
50. TKT maintains intestinal ATP production and inhibits apoptosis-induced colitis.
Tian N; Hu L; Lu Y; Tong L; Feng M; Liu Q; Li Y; Zhu Y; Wu L; Ji Y; Zhang P; Xu T; Tong X
Cell Death Dis; 2021 Sep; 12(10):853. PubMed ID: 34535624
[TBL] [Abstract][Full Text] [Related]
51. Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer.
Xian L; Zhao P; Chen X; Wei Z; Ji H; Zhao J; Liu W; Li Z; Liu D; Han X; Qian Y; Dong H; Zhou X; Fan J; Zhu X; Yin J; Tan X; Jiang D; Yu H; Cao G
Cell Oncol (Dordr); 2022 Oct; 45(5):1019-1036. PubMed ID: 36036881
[TBL] [Abstract][Full Text] [Related]
52. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways.
Li M; He X; Guo W; Yu H; Zhang S; Wang N; Liu G; Sa R; Shen X; Jiang Y; Tang Y; Zhuo Y; Yin C; Tu Q; Li N; Nie X; Li Y; Hu Z; Zhu H; Ding J; Li Z; Liu T; Zhang F; Zhou H; Li S; Yue J; Yan Z; Cheng S; Tao Y; Yin H
Nat Cancer; 2020 Jul; 1(7):735-747. PubMed ID: 35122041
[TBL] [Abstract][Full Text] [Related]
53. Metabolic flexibility of D-ribose producer strain of Bacillus pumilus under environmental perturbations.
Srivastava RK; Maiti SK; Das D; Bapat PM; Batta K; Bhushan M; Wangikar PP
J Ind Microbiol Biotechnol; 2012 Aug; 39(8):1227-43. PubMed ID: 22438109
[TBL] [Abstract][Full Text] [Related]
54. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
55. TKTL1 expression and its downregulation is implicated in cell proliferation inhibition and cell cycle arrest in esophageal squamous cell carcinoma.
Shi Z; Tang Y; Li K; Fan Q
Tumour Biol; 2015 Nov; 36(11):8519-29. PubMed ID: 26032094
[TBL] [Abstract][Full Text] [Related]
56. Evidence for transketolase-like TKTL1 flux in CHO cells based on parallel labeling experiments and (13)C-metabolic flux analysis.
Ahn WS; Crown SB; Antoniewicz MR
Metab Eng; 2016 Sep; 37():72-78. PubMed ID: 27174718
[TBL] [Abstract][Full Text] [Related]
57. PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.
Hong X; Song R; Song H; Zheng T; Wang J; Liang Y; Qi S; Lu Z; Song X; Jiang H; Liu L; Zhang Z
Gut; 2014 Oct; 63(10):1635-47. PubMed ID: 24352616
[TBL] [Abstract][Full Text] [Related]
58. Transketolase Deficiency in Adipose Tissues Protects Mice From Diet-Induced Obesity by Promoting Lipolysis.
Tian N; Liu Q; Li Y; Tong L; Lu Y; Zhu Y; Zhang P; Chen H; Hu L; Meng J; Feng M; Li M; Zheng L; Li B; Xu T; Wu L; Tong X
Diabetes; 2020 Jul; 69(7):1355-1367. PubMed ID: 32295803
[TBL] [Abstract][Full Text] [Related]
59. Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis.
Wang Z; Qiu Z; Hua S; Yang W; Chen Y; Huang F; Fan Y; Tong L; Xu T; Tong X; Yang K; Jin W
Basic Res Cardiol; 2022 Apr; 117(1):18. PubMed ID: 35380314
[TBL] [Abstract][Full Text] [Related]
60. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.
Wu Q; Ge XL; Geng ZK; Wu H; Yang JY; Cao SR; Yang AL
Heliyon; 2024 Feb; 10(3):e25144. PubMed ID: 38322888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
